Patents by Inventor Caren C. Helbing

Caren C. Helbing has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220125873
    Abstract: Antimicrobial peptides (AMPs), small compounds that often exhibitbroad spectrum antimicrobial activity, are garnering interest as potential therapeutics against antibiotic-resistant bacterial pathogens. Development of new AMPs is arduous due to the practical limitations of classical protein-based discovery approaches. A high throughput bioinformatics approach is described which is able to confirm identification of known AMPs from the North American bullfrog (Rana (Lithobates) catesbeiana) genome, and a bioinformatics approach is used to develop new AMPs. The described AMPs exhibit antimicrobial activity against Mycobacterium smegmatis via microtitre broth dilution assays, indicating broader efficacy.
    Type: Application
    Filed: December 10, 2019
    Publication date: April 28, 2022
    Inventors: Inanc BIROL, Caren C. HELBING, Stewart Austin HAMMOND
  • Patent number: 9944994
    Abstract: Described herein are DNA primer sequences designed for the determination of gene or transcript information from Anuran species, and which may be used in studies for developmental and/or toxicity testing and for environmental toxicology or ecological assessment. Also described herein is a rapid, sensitive, high-throughput assay useful for supporting potential risk assessment across vertebrate clades, and that is also useful for evaluation of complex contaminant mixtures.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: April 17, 2018
    Assignee: Arizona Board of Regents on Behalf of Northern Arizona University
    Inventors: Catherine R. Propper, Stephen M. Beckstrom-Sternberg, Caren C. Helbing, Nicholas J. Veldhoen
  • Publication number: 20160340747
    Abstract: Described herein are DNA primer sequences designed for the determination of gene or transcript information from Anuran species, and which may be used in studies for developmental and/or toxicity testing and for environmental toxicology or ecological assessment. Also described herein is a rapid, sensitive, high-throughput assay useful for supporting potential risk assessment across vertebrate clades, and that is also useful for evaluation of complex contaminant mixtures.
    Type: Application
    Filed: August 11, 2016
    Publication date: November 24, 2016
    Applicant: Arizona Board of Regents acting for and on behalf of Northern Arizona University
    Inventors: Catherine R. Propper, Stephen M. Beckstrom-Sternberg, Caren C. Helbing, Nicholas J. Veldhoen
  • Patent number: 9448227
    Abstract: Described herein are DNA primer sequences designed for the determination of gene or transcript information from Anuran species, and which may be used in studies for developmental and/or toxicity testing and for environmental toxicology or ecological assessment. Also described herein is a rapid, sensitive, high-throughput assay useful for supporting potential risk assessment across vertebrate clades, and that is also useful for evaluation of complex contaminant mixtures.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: September 20, 2016
    Assignee: The Arizona Board of Regents on Behalf of Northern Arizona University
    Inventors: Catherine R. Propper, Stephen M. Beckstrom-Sternberg, Caren C. Helbing, Nicholas J. Veldhoen
  • Publication number: 20150094228
    Abstract: Described herein are DNA primer sequences designed for the determination of gene or transcript information from Anuran species, and which may be used in studies for developmental and/or toxicity testing and for environmental toxicology or ecological assessment. Also described herein is a rapid, sensitive, high-throughput assay useful for supporting potential risk assessment across vertebrate clades, and that is also useful for evaluation of complex contaminant mixtures.
    Type: Application
    Filed: October 7, 2014
    Publication date: April 2, 2015
    Inventors: Catherine R. Propper, Stephen M. Beckstrom-Sternberg, Caren C. Helbing, Nicholas J. Veldhoen
  • Patent number: 7754443
    Abstract: A low thyroid hormone serum supplemented culture medium is provided comprising serum prepared from non-mammalian vertebrates having a developmental stage with low endogenous thyroid hormone (T3 and T4) levels; and a culture medium. The culture medium is for the study of cellular responses to thyroid hormones or chemicals that induce or inhibit a cellular response. Methods of preparation and use are also provided.
    Type: Grant
    Filed: October 12, 2006
    Date of Patent: July 13, 2010
    Assignee: University of Victoria Innovation and Development Corporation
    Inventor: Caren C. Helbing
  • Patent number: 6143522
    Abstract: The invention provides novel methods for modulating apoptosis in eukaryotic cells using peptides and proteins derived from p33.sup.ING1 or oligonucleotides derived from the ING1 gene. The invention also provides method of determining the apoptotic characteristic of a eukaryotic cell.
    Type: Grant
    Filed: February 4, 2000
    Date of Patent: November 7, 2000
    Assignee: University Technologies International, Inc.
    Inventors: Caren C. Helbing, Karl Riabowol, Randall N. Johnston, Igor Garkavtsev